APA Zitierstil

Fala, L. (2016). Corlanor (Ivabradine), First HCN Channel Blocker, FDA Approved for the Treatment of Patients with Heart Failure. Am Health Drug Benefits.

Chicago Zitierstil

Fala, Loretta. "Corlanor (Ivabradine), First HCN Channel Blocker, FDA Approved for the Treatment of Patients With Heart Failure." Am Health Drug Benefits 2016.

MLA Zitierstil

Fala, Loretta. "Corlanor (Ivabradine), First HCN Channel Blocker, FDA Approved for the Treatment of Patients With Heart Failure." Am Health Drug Benefits 2016.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.